4//SEC Filing
Galena Biopharma, Inc. 4
Accession 0001394548-17-000015
$SLSCIK 0001390478operating
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 5:02 PM ET
Size
5.2 KB
Accession
0001394548-17-000015
Insider Transaction Report
Form 4
GALLIKER STEPHEN S
Director
Transactions
- Award
Common Stock
2017-04-10$0.59/sh+9,865$5,820→ 13,416 total
Footnotes (2)
- [F1]Effective January 1, 2017, 33% of the cash retainer payment to our Board will be paid in unrestricted shares of the Company's common stock, delivered from the 2016 Incentive Plan and priced on the first trading day of the quarter.
- [F2]Represents the closing stock price of the Company's stock on the first trading day of the quarter.
Documents
Issuer
Galena Biopharma, Inc.
CIK 0001390478
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001390478
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 5:02 PM ET
- Size
- 5.2 KB